London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
With
Academic Medical Organization of Southwestern Ontario
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with oligometastatic non-small cell lung cancer (NSCLC), including a primary lung tumour (± hilar/mediastinal adenopathy) with up to 5 synchronous metastases
Radical treatment intent to all sites is recommended at multi-disciplinary tumour board or by discussion by medical oncologist and radiation oncologist and/or surgeon.
Age 18 years or older
Good performance status (Eastern Cooperative Oncology Group \[ECOG 0-1) with life-expectancy of at least 6 months as determined by enrolling physician
Patient has undergone staging investigations less than 3 months prior to registration.
1. Positron Emission Tomography (PET) / Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) brain (CT brain with contrast if contraindication to MRI) OR
2. CT chest/abdomen, radionucleotide bone scan and MRI of brain (CT brain with contrast if contraindication to MRI)
Pathologic confirmation of NSCLC
You may not be if
Contraindication to Endobronchial Ultrasound (EBUS) / Endoscopic Ultrasound (EUS)
Unable to provide consent for EBUS/EUS
Contraindication to chest radiotherapy
Pregnant or lactating women
Clareo Health | Chest Lymph Node Sampling in Patients With Advanced Lung Cancer to be Treated With Curative-intent Radiation Treatment
